期刊
CLINICAL BREAST CANCER
卷 18, 期 5, 页码 E789-E795出版社
CIG MEDIA GROUP, LP
DOI: 10.1016/j.clbc.2018.03.008
关键词
Quality of life; Radiotherapy; Skin reaction; Skin toxicity; Treatment side effect
类别
资金
- Bratty Family Fund
- Michael and Karyn Goldstein Cancer Research Fund
- Joey and Mary Furfari Cancer Research Fund
- Pulenzas Cancer Research Fund
- Joseph and Silvana Melara Cancer Research Fund
- Ofelia Cancer Research Fund
Radiation dermatitis is a common distressing side effect of breast radiotherapy. This study of 148 patients aimed to determine the trend of radiation dermatitis. Radiation dermatitis appears to peak at 2 weeks after radiotherapy; treatment factors such as technique or dosing regimen do not appear to have a substantial effect, but our study was limited by small sample size. Radiation dermatitis should continue to be followed closely, especially in the 2 weeks following RT. Background: Despite clear benefits of radiotherapy (RT) for breast cancer, there are numerous side effects. Radiation dermatitis has a significant impact on quality of life and can result in treatment interruptions or cessation. The purpose of this study was to prospectively follow breast radiation dermatitis and determine trends including peak toxicity. Patients and Methods: Upon initiation of RT treatment, to assess skin reaction, each patient was seen weekly by the healthcare team, or contacted via telephone to assess patient-reported symptoms. Weekly progression of radiation dermatitis was assessed using the Common Terminology Criteria for Adverse Events (CTCAE), version 4.03. Patients were stratified for analysis of radiation dermatitis based on RT technique and dosage. Results: A total of 148 patients with 2 or more skin assessments were analyzed. The majority of patients received 2-field tangential RT (64.2%) with a dose of 5000 cGy in 25 fractions. Overall, patients experienced the most Grade 2 CTCAE toxicity (61.9%) 2 weeks after completion of RT; Grade 3 toxicity also peaked at this time (8.3%). Regardless of stratification by RT technique or by dosage of RT, Grade 2 and 3 toxicities consistently peaked at 1 or 2 weeks after RT. Conclusions: Breast radiation dermatitis appears to peak approximately 2 weeks after RT. Treatment factors such as technique or dosing regimen do not appear to have a substantial effect on radiation dermatitis, but our study was limited by small sample size. This study provides additional evidence that radiation dermatitis should continue to be followed closely, especially in the 2 weeks following RT. (C) 2018 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据